Search results for: 'infection disease in the developing world'

This research service covers emerging diagnostic technologies that can transform infectious disease management. CRISPR-based diagnostics: CRISPR (clustered regularly interspaced short palindromic repeats) can deliver rapid, portable and accurate diagnostics tests for field applications. This reports deals with two major US-based players developing...

16 Jan 2025  |  Global  |  Technology Research

Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029

The emergence of novel pathogens and the reemergence of old pathogens are driving transformational growth by pushing therapeutic advancement.

Infographics

×

Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an analysis of clinical trials for 3 treatment modaliti...

14 Feb 2022  |  Global  |  Market Research

Global Neurovascular Disease Management Growth Opportunities

AI-based Triaging and Simulation Technology to Aid Expansion of Neurointerventional Stroke Management Procedures

Infographics

×

The global prevalence of stroke is estimated to be about 100 million as of 2021. In the past 30 years, improvements in stroke prevention, acute treatment, and neuro-rehabilitation have contributed to a significant reduction in the burden of stroke in high-income countries. Neurovascular solutions companies recognize the importance of optimized solu...

With persistent geopolitical tensions and the resultant trade fragmentation continuing to shape the global economy, policy priorities among countries advanced and emerging are shifting toward macroeconomic frameworks that will insulate them from external shocks. Incremental reforms that support sustainability and Industry 5.0 practices will have pr...

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

19 Jun 2024  |  Global  |  Technology Research

Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024 2028

Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases

Infographics

×

Neurodegenerative diseases (NDD) pose significant challenges to healthcare systems and affect millions of people worldwide, making early detection crucial. While the current diagnostic strategy is predominantly brain imaging techniques, it is not performed until symptoms are more pronounced. Subtle changes occurring in neural cells during early pro...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

06 Oct 2021  |  North America  |  Market Research

US Chronic Disease Management Growth Opportunities

Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management

Infographics

×

Key Issues Addressed

The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...